Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

66 results about "Hepatic tumour" patented technology

Hepatic tumors are tumors or growths on or in the liver. These growths can be benign or malignant (cancerous).

Method for predicting morphological changes of liver tumor after ablation based on deep learning

The invention discloses a method for predicting the morphological change of a liver tumor after ablation based on deep learning. The method comprises the following steps: acquiring a medical image mapof a patient before and after liver tumor ablation; preprocessing the medical images before and after ablation; obtaining a preoperative liver region map and a preoperative liver tumor region map; acquiring a postoperative liver region map, a postoperative ablation region map and a postoperative liver tumor ghost image; obtaining a transformation matrix by using a CPD point set registration algorithm, and obtaining a registration result graph according to the transformation matrix; training the network through a stochastic gradient descent method to obtain a liver tumor prediction model; andpredicting the morphological change of the liver tumor of the patient after ablation by using the liver tumor prediction model. According to the method, the morphological change of the liver tumor after ablation of the patient can be predicted according to the CT / MRI image of the patient, a basis is provided for quantitatively evaluating whether the ablation area completely covers the tumor, a doctor can accurately evaluate the postoperative curative effect, and a foundation is laid for a subsequent treatment scheme of the patient.
Owner:GENERAL HOSPITAL OF PLA

Liver tumor ablation postoperative three-dimensional space curative effect evaluation method and system

The invention discloses a liver tumor ablation postoperative three-dimensional space curative effect evaluation method and system, and the method comprises the steps: obtaining a medical image map ofa patient, and preprocessing the medical image map; performing image segmentation and three-dimensional modeling on the medical image map to obtain a preoperative liver region, a preoperative liver tumor region, a postoperative liver region and a postoperative ablation region; performing global registration on the preoperative liver region and the postoperative liver region by using a CPD point set registration algorithm to obtain a transformation matrix, and then calculating a registration result tumor region corresponding to the preoperative liver tumor region after the ablation operation;performing extraction and local registration on the common features, and then adjusting a tumor region of a registration result; and calculating the distance between the postoperative ablation area and the boundary of the registration result tumor area, and visually displaying the distance in a three-dimensional space. The invention can assist a doctor in evaluating the curative effect after ablation, and lays a foundation for making a follow-up treatment scheme of a patient.
Owner:GENERAL HOSPITAL OF PLA

Liver tumor recognition method based on self-supervised dense convolutional neural network

The invention discloses a liver tumor recognition method based on a self-supervised dense convolutional neural network. The method comprises the following steps: obtaining a liver slice data set from a magnetic resonance image of a patient, carrying out the segmentation of the slice data set, training a constructed dense convolutional network, enabling the trained dense convolutional network to serve as a coding module, constructing a self-supervised learning network, and carrying out the recognition of a liver tumor through the self-supervised learning network. Through dense connection of the coding modules, a tumor region of a part of an image in a slice data set is manually marked, then the whole slice data set is segmented, segmented image blocks are adopted to train a self-supervised learning network, and the trained self-supervised learning network is adopted to automatically identify tumors in the image. The dense convolutional neural network based on self-supervision is used for liver tumor recognition, a puzzle task is set as a self-supervision upstream training task, useful representations are learned from a large number of images which are not subjected to medical labeling and are used for learning training of downstream target tasks, and therefore the purposes of automatically expanding training data samples and improving the recognition efficiency are achieved. The dependence on expert experience and historical data is reduced, and the recognition accuracy of the liver lesion region is improved.
Owner:SECOND AFFILIATED HOSPITAL OF XIAN MEDICAL UNIV

Preparation method and application of effective component of trumpetcreeper

InactiveCN101856375AThe method of effective components is simpleComponent method is simpleAntineoplastic agentsPlant ingredientsOral medicationSilica gel
The invention provides a preparation method of an effective component of trumpetcreeper, which comprises the following steps: extracting a medicinal material by heating, concentrating, separating by a silica gel column, and eluting; concentrating and drying eluent, and continuing to separate by preparative liquid chromatography; and collecting solution, and obtaining the effective component after the solution is concentrated and dried. The effective component of the trumpetcreeper can be taken as an active ingredient and is added with medicinally accepted excipients or carriers to be prepared into a preparation according to the method recorded in pharmacy, and the preparation of the prepared drug comprises a liquid preparation, a solid preparation, a capsule preparation or a pill preparation; and the administration comprises oral administration or injection administration. The effective component of the trumpetcreeper provided by the invention can be applied in the preparation of drugs for treating and preventing tumor. The preparation method of the invention has simple operation and stable quality, and no report that the trumpetcreeper can resist the activity of liver tumor exists in the prior art, so the preparation method provides a research basis for research and development of novel trumpetcreeper anti-tumor drugs.
Owner:ZHEJIANG UNIV

Defining method, establishing system and application of tumor excision margin distance field

The invention provides a method for establishing a tumor excision margin distance field model, and aims to solve the problems of high surgical risk and long surgical time in a liver tumor excision process in the prior art. The invention provides a method for defining a tumor incisal margin distance field, which comprises the following steps of: S1, acquiring imaging data of a patient, and establishing a model of a relative position relationship between a tumor and each tissue; s2, calling relative position information between the tumor and each tissue to judge the resection property of the tumor, if so, entering step S3, and if not, ending; s3, establishing an envelope surface according to the outer contour information of the tumor surface; and S4, determining a cutting edge surface and an edge distance field according to the envelope surface. The model is established to simulate the relative position relation of the tumor in the human body, and meanwhile, the risk in the operation is reduced, and the operation duration is shortened. The invention further discloses application of the defining method of the tumor excision margin distance field to positioning of the distance between a scalpel and a tumor in the liver resection operation process. The invention further discloses a system for establishing the tumor incisional margin distance field.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV +2

Liver tumor early recurrence prediction method based on 3D CNN and LSTM

The invention provides a liver tumor early recurrence prediction method based on 3D CNN and LSTM. The method comprises the following steps: acquiring a CT image and clinical information of an HCC patient, and counting postoperative ER information of the HCC patient; carrying out image segmentation on the CT image, and then dividing obtained data samples into a training set and a test set; training by using the training set to obtain a 3D CNN model of a mapping relation between the CT image and the ER information; extracting iconography features of the data sample corresponding to the liver tumor area, performing dimension reduction on the extracted iconography features by using an LASSO logistic algorithm, and selecting out iconography features useful for ER prediction; carrying out statistical analysis on the clinical information, carrying out ER clinical factor univariate analysis by utilizing chi-square test, and selecting a clinical factor corresponding to a test level P less than 0.05; and training to obtain an optimal LSTM model by using features obtained by a 3D CNN model, imaging features useful for ER prediction and clinical factors corresponding to a test level P less than 0.05, and predicting the ER of an HCC patient by using the LSTM model.
Owner:PLA STRATEGIC SUPPORT FORCE INFORMATION ENG UNIV PLA SSF IEU

Mesoporous silica nano composite carrier, drug-loaded compound, application and pharmaceutical composition

The invention relates to the technical field of medicine, in particular to a mesoporous silica nano composite carrier, a drug-loaded compound, application and a pharmaceutical composition. The mesoporous silica nano composite carrier comprises a nano-cluster core with magnetic imaging characteristics and an organic mesoporous silica shell wrapping the nano-cluster core, and the surface of the organic mesoporous silica shell is modified with optical imaging molecules. The mesoporous silica nano-composite carrier can effectively load active drugs, then has a good treatment effect on liver tumors, can be deposited at a high concentration locally on the tumors, then continuously releases the loaded active drugs, and further kills tumor cells. Meanwhile, after the composite carrier is loaded with the active drugs and enters a body, the multi-modal imaging effect is achieved by utilizing the characteristics of magnetic resonance imaging and optical imaging of the composite carrier, so that the release, the drug effect, the mechanism and the like of the drugs are effectively detected, and the composite carrier has important clinical identification and research significance.
Owner:NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products